3zo4
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors== | ==The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors== | ||
- | <StructureSection load='3zo4' size='340' side='right' caption='[[3zo4]], [[Resolution|resolution]] 1.65Å' scene=''> | + | <StructureSection load='3zo4' size='340' side='right'caption='[[3zo4]], [[Resolution|resolution]] 1.65Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3zo4]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3zo4]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ZO4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ZO4 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=QWI:6-(4-PHENYL-1,9-DIAZASPIRO[5.5]UNDECAN-9-YL)-9H-PURINE'>QWI</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=QWI:6-(4-PHENYL-1,9-DIAZASPIRO[5.5]UNDECAN-9-YL)-9H-PURINE'>QWI</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3zo4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3zo4 OCA], [https://pdbe.org/3zo4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3zo4 RCSB], [https://www.ebi.ac.uk/pdbsum/3zo4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3zo4 ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/IPKA_BOVIN IPKA_BOVIN] Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains (By similarity). |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 21: | ||
==See Also== | ==See Also== | ||
- | *[[CAMP-dependent protein kinase|CAMP-dependent protein kinase]] | + | *[[CAMP-dependent protein kinase 3D structures|CAMP-dependent protein kinase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Bos taurus]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Allen | + | [[Category: Allen CE]] |
- | [[Category: Caldwell | + | [[Category: Caldwell JJ]] |
- | [[Category: Chow | + | [[Category: Chow CL]] |
- | [[Category: Collins | + | [[Category: Collins I]] |
- | + | [[Category: Westwood IM]] | |
- | [[Category: Westwood | + | [[Category: Van Montfort RL]] |
- | [[Category: | + |
Current revision
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors
|